OBSOLETE: Lumbosacral spina bifida cystica

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268758
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Lumbosacral spina bifida cystica is an obsolete Orphanet classification (Orphanet code 268758) that previously referred to a specific subtype of neural tube defect (NTD) in which the spinal column fails to close properly during embryonic development in the lumbosacral region (lower back and sacrum), resulting in a cyst-like protrusion containing meninges and/or spinal cord tissue. This condition encompasses both meningocele (protrusion of meninges only) and myelomeningocele (protrusion of both meninges and spinal cord) localized to the lumbosacral spine. The term has been retired as a distinct entity in Orphanet and is now classified under broader categories of spina bifida cystica or open spinal dysraphism. Clinically, lumbosacral spina bifida cystica affects the nervous system, musculoskeletal system, and urogenital system. Key features include lower limb weakness or paralysis, sensory loss below the level of the defect, bladder and bowel dysfunction (neurogenic bladder and bowel), and orthopedic complications such as clubfoot and hip dysplasia. Hydrocephalus frequently co-occurs, often associated with Chiari II malformation. The condition is apparent at birth, with the visible cystic lesion on the lower back being the hallmark finding. Management is multidisciplinary and typically involves surgical closure of the defect shortly after birth to prevent infection and further neurological damage. Hydrocephalus may require ventriculoperitoneal shunt placement. Ongoing care includes urological management, physical therapy, orthopedic interventions, and neurodevelopmental support. Prenatal folic acid supplementation is a well-established preventive measure that significantly reduces the risk of neural tube defects. Prenatal surgical repair (fetal surgery) has also shown benefits in reducing the severity of associated complications, as demonstrated by the MOMS trial.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Lumbosacral spina bifida cystica.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Lumbosacral spina bifida cystica at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Lumbosacral spina bifida cystica community →

No specialists are currently listed for OBSOLETE: Lumbosacral spina bifida cystica.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Lumbosacral spina bifida cystica.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Lumbosacral spina bifida cysticaForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Lumbosacral spina bifida cystica.

Start the conversation →

Latest news about OBSOLETE: Lumbosacral spina bifida cystica

No recent news articles for OBSOLETE: Lumbosacral spina bifida cystica.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Lumbosacral spina bifida cystica

What is OBSOLETE: Lumbosacral spina bifida cystica?

Lumbosacral spina bifida cystica is an obsolete Orphanet classification (Orphanet code 268758) that previously referred to a specific subtype of neural tube defect (NTD) in which the spinal column fails to close properly during embryonic development in the lumbosacral region (lower back and sacrum), resulting in a cyst-like protrusion containing meninges and/or spinal cord tissue. This condition encompasses both meningocele (protrusion of meninges only) and myelomeningocele (protrusion of both meninges and spinal cord) localized to the lumbosacral spine. The term has been retired as a distinct

How is OBSOLETE: Lumbosacral spina bifida cystica inherited?

OBSOLETE: Lumbosacral spina bifida cystica follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Lumbosacral spina bifida cystica typically begin?

Typical onset of OBSOLETE: Lumbosacral spina bifida cystica is neonatal. Age of onset can vary across affected individuals.